Zosano Pharma Corp Financing Cash Flow
Zosano Pharma Corp reported Financing Cash Flow of $11.09 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-05-13
- Zosano Pharma Corp net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $11.09M, a 379.09% increase year-over-year.
- Zosano Pharma Corp net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $135.00K.
- Zosano Pharma Corp net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $2.00M, a 95.56% decline year-over-year.
- Zosano Pharma Corp net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $4.35M, a 31.25% increase year-over-year.
- Zosano Pharma Corp net cash provided by (used in) financing activities for fiscal 2021 was $8.79M, a 87.28% decline from fiscal 2020.
- Zosano Pharma Corp net cash provided by (used in) financing activities for fiscal 2020 was $69.15M, a 131.83% increase from fiscal 2019.
- Zosano Pharma Corp net cash provided by (used in) financing activities for fiscal 2019 was $29.83M, a 34.91% decline from fiscal 2018.
- Zosano Pharma Corp net cash provided by (used in) financing activities for fiscal 2018 was $45.82M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | $11.09M 10-Q · filed 2022-05-13 | $11.23M derived: sum of 2 quarters · filed 2022-05-13 | $13.22M derived: sum of 3 quarters · filed 2022-05-13 | $17.57M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.13M derived: sum of 2 quarters · filed 2022-03-17 | $6.48M derived: sum of 3 quarters · filed 2022-03-17 | $8.79M 10-K · filed 2022-03-17 |
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $6.34M derived: sum of 2 quarters · filed 2021-11-10 | $8.66M 10-Q · filed 2021-11-10 | $7.42M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $6.66M 10-Q · filed 2021-08-10 | $5.43M derived: sum of 3 quarters · filed 2022-05-13 | $50.43M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $2.31M 10-Q · filed 2022-05-13 | $1.08M derived: sum of 2 quarters · filed 2022-05-13 | $46.09M derived: sum of 3 quarters · filed 2022-05-13 | $49.40M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $43.77M derived: sum of 2 quarters · filed 2022-03-17 | $47.08M derived: sum of 3 quarters · filed 2022-03-17 | $69.15M 10-K · filed 2022-03-17 |
| 2020-09-30 | $45.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $48.32M derived: sum of 2 quarters · filed 2021-11-10 | $70.39M 10-Q · filed 2021-11-10 | $78.50M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $25.38M 10-Q · filed 2021-08-10 | $33.49M derived: sum of 3 quarters · filed 2021-08-10 | $35.70M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $22.07M 10-Q · filed 2021-05-12 | $30.18M derived: sum of 2 quarters · filed 2021-05-12 | $32.38M derived: sum of 3 quarters · filed 2021-05-12 | $52.41M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $10.31M derived: sum of 2 quarters · filed 2021-03-11 | $30.34M derived: sum of 3 quarters · filed 2021-03-11 | $29.83M 10-K · filed 2021-03-11 |
| 2019-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $22.23M derived: sum of 2 quarters · filed 2020-11-13 | $21.72M 10-Q · filed 2020-11-13 | $23.33M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $20.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $19.52M 10-Q · filed 2020-08-06 | $21.13M derived: sum of 3 quarters · filed 2020-08-06 | $22.82M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$513.00K 10-Q · filed 2020-05-14 | $1.10M derived: sum of 2 quarters · filed 2020-05-14 | $2.79M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.30M derived: sum of 2 quarters · filed 2020-03-13 | $45.82M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $44.21M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $42.52M 10-Q · filed 2019-08-14 | |||
| 2017-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-15 | $26.49M 10-Q · filed 2018-11-15 | ||
| 2017-06-30 | $27.95M 10-Q · filed 2018-08-09 |